| Literature DB >> 35974013 |
Sebastian Schmidt1,2, Malte D Luecken3, Dietrich Trümbach1,4, Sina Hembach1,2, Kristina M Niedermeier1,2, Nicole Wenck1,2, Klaus Pflügler1,2, Constantin Stautner1,2, Anika Böttcher5, Heiko Lickert5, Ciro Ramirez-Suastegui3, Ruhel Ahmad6, Michael J Ziller7, Julia C Fitzgerald8, Viktoria Ruf9,10, Wilma D J van de Berg11, Allert J Jonker11, Thomas Gasser8, Beate Winner12, Jürgen Winkler13, Daniela M Vogt Weisenhorn1,2, Florian Giesert14, Fabian J Theis15,16, Wolfgang Wurst17,18,19,20.
Abstract
Parkinson's disease (PD) as a progressive neurodegenerative disorder arises from multiple genetic and environmental factors. However, underlying pathological mechanisms remain poorly understood. Using multiplexed single-cell transcriptomics, we analyze human neural precursor cells (hNPCs) from sporadic PD (sPD) patients. Alterations in gene expression appear in pathways related to primary cilia (PC). Accordingly, in these hiPSC-derived hNPCs and neurons, we observe a shortening of PC. Additionally, we detect a shortening of PC in PINK1-deficient human cellular and mouse models of familial PD. Furthermore, in sPD models, the shortening of PC is accompanied by increased Sonic Hedgehog (SHH) signal transduction. Inhibition of this pathway rescues the alterations in PC morphology and mitochondrial dysfunction. Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological phenotypes observed in sPD like mitochondrial dysfunction. Inhibiting overactive SHH signaling may be a potential neuroprotective therapy for sPD.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35974013 PMCID: PMC9380673 DOI: 10.1038/s41467-022-32229-9
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694